The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study

J. Riedl, F. Posch, G. Prager, W. Eisterer, L. Öhler, S. Thamer, K. Wilthoner, A. Petzer, P. Pichler, E. Hubmann, T. Winder, S. Burgstaller, M. Korger, J. Andel, R. Greil, M. Pecherstorfer, K. Philipp-abbrederis, A. Djanani, B. Gruenberger, F. LängleE. Wöll, A. Gerger

Research output: Contribution to book/report/conference proceedingContribution to conference proceeding

Original languageEnglish
Title of host publicationAnnals of Oncology
Publication statusPublished - 01 Jul 2019

Cite this